Julie Litz

1.7k total citations
20 papers, 1.4k citations indexed

About

Julie Litz is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Julie Litz has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Julie Litz's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Mechanisms and Therapy (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Julie Litz is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Mechanisms and Therapy (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Julie Litz collaborates with scholars based in United States and Switzerland. Julie Litz's co-authors include Geoffrey W. Krystal, Elisabeth Buchdunger, Sittisak Honsawek, Francesco Hofmann, Sarah J. Parsons, Carlos García-Echeverría, Paula M. Hauck, Constance M. Ely, Thomas W. Sturgill and Anthony Rossomando and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The Journal of Physical Chemistry B.

In The Last Decade

Julie Litz

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Litz United States 18 885 511 193 159 155 20 1.4k
Glen S. Germain United States 17 986 1.1× 558 1.1× 97 0.5× 142 0.9× 155 1.0× 30 1.6k
Hanibal Bohnenberger Germany 22 690 0.8× 428 0.8× 191 1.0× 114 0.7× 238 1.5× 86 1.6k
Anna Garuti Italy 21 644 0.7× 477 0.9× 122 0.6× 205 1.3× 254 1.6× 67 1.5k
Maria Luisa Veronese United States 18 969 1.1× 678 1.3× 98 0.5× 109 0.7× 190 1.2× 35 1.8k
Christine Fritsch Switzerland 21 1.8k 2.0× 610 1.2× 213 1.1× 129 0.8× 258 1.7× 39 2.6k
Toshihiro Mochizuki Japan 17 780 0.9× 302 0.6× 163 0.8× 155 1.0× 120 0.8× 27 1.3k
Mei Dong China 18 1.2k 1.4× 539 1.1× 99 0.5× 167 1.1× 332 2.1× 36 1.7k
Kathleen D. Whitney United States 16 775 0.9× 695 1.4× 132 0.7× 42 0.3× 318 2.1× 25 1.6k
Ute Hamann Germany 23 1.1k 1.2× 389 0.8× 105 0.5× 90 0.6× 556 3.6× 67 2.1k
Louis Hornez France 17 784 0.9× 407 0.8× 99 0.5× 91 0.6× 205 1.3× 41 1.4k

Countries citing papers authored by Julie Litz

Since Specialization
Citations

This map shows the geographic impact of Julie Litz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Litz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Litz more than expected).

Fields of papers citing papers by Julie Litz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Litz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Litz. The network helps show where Julie Litz may publish in the future.

Co-authorship network of co-authors of Julie Litz

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Litz. A scholar is included among the top collaborators of Julie Litz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Litz. Julie Litz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Litz, Julie, et al.. (2025). The Lysine Deprotonation Mechanism in a Ubiquitin Conjugating Enzyme. The Journal of Physical Chemistry B. 129(20). 4962–4968.
2.
DeVries, George H., et al.. (2012). Didox‐A Multipotent Drug for Treating Demyelinating disease. The FASEB Journal. 26(S1). 2 indexed citations
3.
Hauck, Paula M., Bo H. Chao, Julie Litz, & Geoffrey W. Krystal. (2009). Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737. Molecular Cancer Therapeutics. 8(4). 883–892. 63 indexed citations
4.
Rodina, Anna, Maria Vilenchik, Kamalika Moulick, et al.. (2007). Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nature Chemical Biology. 3(8). 498–507. 129 indexed citations
5.
Litz, Julie, et al.. (2007). Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Lung Cancer. 60(2). 166–174. 33 indexed citations
6.
Litz, Julie & Geoffrey W. Krystal. (2006). Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells. Molecular Cancer Therapeutics. 5(6). 1415–1422. 80 indexed citations
7.
Litz, Julie, et al.. (2005). The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy. Clinical Cancer Research. 11(4). 1563–1571. 143 indexed citations
8.
9.
10.
Litz, Julie, et al.. (2003). Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction.. PubMed. 9(12). 4586–94. 23 indexed citations
11.
Krystal, Geoffrey W., et al.. (2002). Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.. PubMed. 1(11). 913–22. 144 indexed citations
12.
Litz, Julie, et al.. (2000). Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.. PubMed. 11(6). 305–14. 36 indexed citations
13.
Krystal, Geoffrey W., Sittisak Honsawek, Julie Litz, & Elisabeth Buchdunger. (2000). The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.. PubMed. 6(8). 3319–26. 230 indexed citations
14.
Hines, Susan J., Julie Litz, & Geoffrey W. Krystal. (1999). Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors. Breast Cancer Research and Treatment. 58(1). 1–10. 37 indexed citations
15.
Krystal, Geoffrey W., et al.. (1998). Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.. PubMed. 58(20). 4660–6. 61 indexed citations
16.
Krystal, Geoffrey W., Patricia L. Carlson, & Julie Litz. (1997). Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.. PubMed. 57(11). 2203–8. 28 indexed citations
17.
Hylemon, Phillip B., Emily C. Gurley, R. Todd Stravitz, et al.. (1992). Hormonal regulation of cholesterol 7 alpha-hydroxylase mRNA levels and transcriptional activity in primary rat hepatocyte cultures.. Journal of Biological Chemistry. 267(24). 16866–16871. 108 indexed citations
18.
Stratton, Kathleen, Paul Worley, Julie Litz, et al.. (1991). Electroconvulsive Treatment Induces a Rapid and Transient Increase in Tyrosine Phosphorylatin of a 40‐Kilodalton Protein Associated with Microtubule‐Associated Protein 2 Kinase Activity. Journal of Neurochemistry. 56(1). 147–152. 55 indexed citations
19.
Ely, Constance M., Julie Litz, Anthony Rossomando, et al.. (1990). A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts.. The Journal of Cell Biology. 110(3). 731–742. 137 indexed citations
20.
Litz, Julie, et al.. (1989). Modulation of pp60c‐src tyrosine kinase activity during secretion in stimulated bovine adrenal chromaffin cells. Journal of Neuroscience Research. 24(1). 38–48. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glen S. Germain Breakdown of academic impact, for papers by Hanibal Bohnenberger Breakdown of academic impact, for papers by Anna Garuti Breakdown of academic impact, for papers by Maria Luisa Veronese Breakdown of academic impact, for papers by Christine Fritsch Breakdown of academic impact, for papers by Toshihiro Mochizuki Breakdown of academic impact, for papers by Mei Dong Breakdown of academic impact, for papers by Kathleen D. Whitney Breakdown of academic impact, for papers by Ute Hamann Breakdown of academic impact, for papers by Louis Hornez
Rankless by CCL
2026